AstraZeneca fails to generic Seroquel in U.S.
March 09, 2012 at 07:52 AM EST
The U.S. Food & Drug Administration has blocked AstraZeneca PLC’s attempt to delay the entry of generic versions of the U.K. drug maker’s anti-psychotic blockbuster Seroquel in the U.S. later this month.
